Co-Director, Duke Comprehensive Hemostasis and Thrombosis Center
Director, Duke Pediatric Sickle Cell Clinic
Department / Division:
Pediatrics
/
Hematology-Oncology
Address:
DUMC 102382
Durham, NC 27710
Appointment Telephone:
919-684-3401
Office Telephone:
919-684-3401
Fax Telephone:
919-681-7950
Training:
MD, Duke University School of Medicine, 1998
Residency:
Pediatrics, Duke University Medical Center, 1998-2001
Fellowship:
Pediatric Hematology/Oncology, University of Michigan, 2001-2004
National Hemophilia Foundation Clinical Fellowship in Hemostasis and Thrombosis, University of Michigan, 2003-2005
Other Degrees:
MS, Clinical Research Design and Statistical Analysis, University of Michigan, 2005
Clinical Interests:
Bleeding, thrombotic, and hematologic disorders in children
Research Interests:
Pediatric Thrombosis -CDC Thrombosis and Hemostasis Center Pilot Sites Registry -Transfusion Medicine and Clinical Trials Network -Pediatrc Warfarin Pharmacogenetics Study
Hemophilia -Hemophilia Inhibitor Genetics Study
ITP -North American Chronic ITP Registry
Sickle Cell Anemia -Toddler Hydroxyurea Group Study -Phase III Pediatric Hydroxyurea Clinical Trial (BABYHUG) -Adherence with Hydroxyurea in Children with Sickle Cell Anemia -Sickle Cell Clinical Research Network -PROMIS
Representative Publications:
Thornburg CD. Physicians' perceptions of adherence to prophylactic clotting factor infusions. Haemophilia. 2008 Jan;14(1):25-9.
(2008)
Abstract
Thornburg CD, Dixon N, Paulyson-Nuñez K, Ortel T. Thrombophilia screening in asymptomatic children. Thromb Res. 2008;121(5):597-604.
(2008)
Abstract
Thornburg CD, Smith PB, Smithwick ML, Cotten CM, Benjamin DK Jr. Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thromb Res. 2007 Nov 9.
(2007)
Abstract
Thornburg CD, Pipe SW. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia. Haemophilia. 2006 Mar;12(2):198-9.
(2006)
Abstract